Citadel Advisors’s Prenetics Global PRE Stock Holding History

Citadel Advisors’s Portfolio PRE Stock Details PRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$199K	Buy	10,300 +200	+2%	+$3.72K	﹤0.01%	11428
2025 Q4	$159K	Buy	+10,100	New	+$147K	﹤0.01%	11247

Other funds holding PRE

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

TGM

Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors's PRE Position: Q1 2023 in Review

Citadel Advisors sold out of Prenetics Global (PRE) in Q1 2023, closing a stake of 733 shares — an estimated $22K sold.

Citadel Advisors first reported a position in PRE in Q2 2022 and held it in 2 quarters. The position peaked at $47K in Q2 2022. 14 funds tracked by Wall St. Rank hold PRE as of Q1 2023.

Citadel Advisors reported no remaining Prenetics Global position as of Q1 2023 after selling out during the quarter.
Citadel Advisors sold 733 Prenetics Global shares in Q1 2023, an estimated $22K.
Citadel Advisors first reported a position in Prenetics Global in Q2 2022 and held it in 2 quarters.
Citadel Advisors's Prenetics Global position peaked at $47K in Q2 2022.
14 funds tracked by Wall St. Rank held Prenetics Global as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.